明基醫 (4116)
明基醫 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$420.97M, down 4.4% from a year earlier. EPS over the last four quarters totals NT$2.64.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2015-12-16
- Founded
- 1989-03-21
- Paid-in capital
- NT$445.66M
- Common shares issued
- 44,566,000
- Legal name
- 明基三豐醫療器材股份有限公司
- Website
- https://www.BenQMedicalTech.com
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$420.97M | +0.8% | -4.4% |
| 2026-08 | NT$417.67M | -3.2% | +0.9% |
Year to date: +3.7% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 1.33 |
| 2026 Q1 | 0.28 |
| 2025 Q4 | 0.41 |
| 2025 Q3 | 0.62 |
| 2025 Q2 | 0.22 |
| 2025 Q1 | 0.50 |
| 2024 Q4 | 0.59 |
| 2024 Q3 | 0.60 |
Last four quarters: NT$2.64
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 2.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 884 | 0.3% |
| 1,000–5,000 shares | 2,816 | 11.8% |
| 5,001–10,000 shares | 302 | 5.4% |
| 10,001–15,000 shares | 116 | 3.3% |
| 15,001–20,000 shares | 66 | 2.8% |
| 20,001–30,000 shares | 57 | 3.2% |
| 30,001–40,000 shares | 28 | 2.2% |
| 40,001–50,000 shares | 10 | 1.1% |
| 50,001–100,000 shares | 21 | 3.4% |
| 100,001–200,000 shares | 22 | 7.2% |
| 200,001–400,000 shares | 8 | 4.4% |
| 400,001–600,000 shares | 0 | 0.0% |
| 600,001–800,000 shares | 0 | 0.0% |
| 800,001–1,000,000 shares | 0 | 0.0% |
| 1,000,001+ shares | 3 | 55.0% |
TDCC data for 2026-10-16: 3 holders own more than 1,000 lots (55.0% of shares), and 884 hold less than one lot (0.3%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 3 | 0 | 0 | 3 |
| 2026-10-16 | 0 | 0 | 0 | 0 |
| 2026-10-15 | 7 | 0 | 0 | 7 |
| 2026-10-14 | 5 | 0 | 0 | 5 |
| 2026-10-13 | 1 | 0 | 0 | 1 |
| 2026-10-12 | 3 | 0 | 0 | 3 |
| 2026-10-08 | 1 | 0 | 0 | 1 |
| 2026-10-07 | -2 | 0 | 0 | -2 |
| 2026-10-06 | -6 | 0 | 0 | -6 |
| 2026-10-05 | -6 | 0 | 0 | -6 |
| 2026-10-02 | -3 | 0 | 0 | -3 |
| 2026-10-01 | -3 | 0 | 0 | -3 |
| 2026-09-30 | -2 | 0 | 0 | -2 |
| 2026-09-29 | -1 | 0 | -1 | -2 |
| 2026-09-24 | -4 | 0 | 0 | -4 |
| 2026-09-23 | -1 | 0 | 0 | -1 |
| 2026-09-22 | -6 | 0 | 0 | -6 |
| 2026-09-21 | 0 | 0 | 0 | 0 |
| 2026-09-17 | -4 | 0 | 0 | -4 |
| 2026-09-16 | -3 | 0 | 0 | -3 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net sellers of 22 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$39.90 (2026-10-19); 52-week range NT$36.65–49.90.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.